The Lancet Diabetes & Endocrinology Journal Citation Rate 2026

ISSN 2213-8587 eISSN 2213-8595 Elsevier NL

Q1 Quartile Top Tier Verified Publisher

About The Lancet Diabetes & Endocrinology

The Lancet Diabetes & Endocrinology (LDE) is a peer-reviewed academic journal, published by Elsevier in NL. It is catalogued under ISSN 2213-8587 (electronic ISSN 2213-8595).

The Lancet Diabetes & Endocrinology Citation Rate 2026 — In Context

The Lancet Diabetes & Endocrinology has a 2025 2-Year Citation Rate (OpenAlex) of 14.81, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not a OpenAlex Journal Impact Factor.

The Lancet Diabetes & Endocrinology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in The Lancet Diabetes & Endocrinology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare The Lancet Diabetes & Endocrinology against similar journals in the field, use our journal comparison tool.

ISSN (Print) 2213-8587
ISSN (Online) 2213-8595
Publisher Elsevier
Country Netherlands
APC / Cost Inquire with Publisher
In-depth profile & metrics

The Lancet Diabetes & Endocrinology is published by Elsevier and based in Netherlands.

Its most recent citation rate stands at 14.808.

Links
Frequently Asked Questions about The Lancet Diabetes & Endocrinology

The current impact factor of The Lancet Diabetes & Endocrinology is 14.808.

No, The Lancet Diabetes & Endocrinology is not an open access journal.

The Lancet Diabetes & Endocrinology is published by Elsevier.

The Lancet Diabetes & Endocrinology is not currently listed in the major indexes we track (Scopus, DOAJ, Web of Science). This is not evidence of predatory practice — many legitimate new or regional journals are not yet indexed — but you should verify its peer-review process, editorial board, and indexing directly with the publisher before submitting.

The ISSN of The Lancet Diabetes & Endocrinology is 2213-8587. Its electronic ISSN (eISSN) is 2213-8595.

The Lancet Diabetes & Endocrinology sits in the Q1 quartile based on its latest impact factor of 14.81, ranked across all journals in our database.
Live Indexing Status
Updated March 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
14.808
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 14.808 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Metadata

Last updated: Mar 15, 2026

Updated by: system

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google